| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |